Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking

Last updated: September 7, 2021
Sponsor: Benha University
Overall Status: Active - Recruiting

Phase

4

Condition

Dry Eye Disease

Sjogren's Syndrome

Dry Eyes

Treatment

N/A

Clinical Study ID

NCT05045053
Hamaky17
  • Ages > 18
  • All Genders

Study Summary

dry eye disease after corneal collagen cross linking affect ocular function leading to reduced vision, photophobia, glare, halos, and foreign body sensation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • corneal collagen cross linking

Exclusion

Exclusion Criteria:

  • systemic or ocular diseases ,previous ocular surgery, corneal pathology and contactlens wearers

Study Design

Total Participants: 40
Study Start date:
February 01, 2021
Estimated Completion Date:
January 31, 2022

Study Description

first group of patients were treated with 0.5 % xiidra twice daily and artificial tears for 6 months.Second group treated with artificial tears for 6 months. the treatment starts after corneal collagen cross linking in both groups ,Baseline and post-treatment full ophthalmic examination was done.

Connect with a study center

  • INMC

    Abu Dhabi, 46266
    United Arab Emirates

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.